Nephrology and Dialysis-Related Anemia
Genexine Inc. focuses on anemia associated with chronic kidney disease in patients receiving hemodialysis, with particular attention to maintaining hemoglobin control in this clinical setting.
- Chronic kidney disease on dialysis
- Hemodialysis-associated anemia
- Hemoglobin level management
The sponsor’s active work in this area is centered on supportive care for patients with advanced kidney disease.
Erythropoiesis and Red Blood Cell Support
The company’s clinical research includes therapies aimed at improving erythropoiesis and supporting red blood cell production in patients with renal-related anemia.
- Erythropoietin-based treatment
- Hemoglobin stabilization
- Renal anemia management
This area reflects a strong therapeutic interest in blood-related complications of kidney failure.
Comparative Supportive Care in Renal Medicine
Genexine’s funded trials address comparative treatment options used in the management of dialysis-related anemia, with emphasis on clinical effectiveness in routine renal care.
- Supportive care in dialysis patients
- Renal medicine treatment evaluation
- Anemia control in CKD
Its research activity is concentrated on treatment choices relevant to long-term care for patients with advanced kidney disease.
